Clinical Trials · NCT03547427
Glucagon Counterregulation in Type 1 Diabetes
- Phase
- N/A
- Recruitment status
- Terminated
- Sponsor
- University of Virginia
- Enrollment
- 13
- Start date
- May 2018
- Locations
- 1 site, United States
- Primary endpoint
- Relative glucagon counterregulation (GCR) response